204 related articles for article (PubMed ID: 1389934)
21. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
[TBL] [Abstract][Full Text] [Related]
22. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
23. Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.
Kokki M; Heikkinen M; Välitalo P; Hautajärvi H; Hokkanen J; Pitkänen H; Sankilampi U; Ranta VP; Kokki H
Br J Clin Pharmacol; 2017 Apr; 83(4):791-800. PubMed ID: 27780305
[TBL] [Abstract][Full Text] [Related]
24. Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.
Andreassen TN; Klepstad P; Davies A; Bjordal K; Lundström S; Kaasa S; Dale O
Eur J Clin Pharmacol; 2011 May; 67(5):493-506. PubMed ID: 21140139
[TBL] [Abstract][Full Text] [Related]
25. CYP3A5*3 affects plasma disposition of noroxycodone and dose escalation in cancer patients receiving oxycodone.
Naito T; Takashina Y; Yamamoto K; Tashiro M; Ohnishi K; Kagawa Y; Kawakami J
J Clin Pharmacol; 2011 Nov; 51(11):1529-38. PubMed ID: 21209234
[TBL] [Abstract][Full Text] [Related]
26. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups.
Liukas A; Kuusniemi K; Aantaa R; Virolainen P; Neuvonen M; Neuvonen PJ; Olkkola KT
Drugs Aging; 2011 Jan; 28(1):41-50. PubMed ID: 21174486
[TBL] [Abstract][Full Text] [Related]
27. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):264-70. PubMed ID: 17098487
[TBL] [Abstract][Full Text] [Related]
28. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
Saari TI; Grönlund J; Hagelberg NM; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Eur J Clin Pharmacol; 2010 Apr; 66(4):387-97. PubMed ID: 20076952
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
Huang L; Edwards SR; Smith MT
Pharm Res; 2005 Sep; 22(9):1489-98. PubMed ID: 16132361
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
Kokki H; Rasanen I; Reinikainen M; Suhonen P; Vanamo K; Ojanperä I
Clin Pharmacokinet; 2004; 43(9):613-22. PubMed ID: 15217304
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.
Cheremina O; Bachmakov I; Neubert A; Brune K; Fromm MF; Hinz B
Biomed Chromatogr; 2005 Dec; 19(10):777-82. PubMed ID: 15920700
[TBL] [Abstract][Full Text] [Related]
32. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.
Samolsky Dekel BG; Donati G; Vasarri A; Croci Chiocchini AL; Gori A; Cavallari G; Di Nino G; Mercolini L; Protti M; Mandrioli R; Melotti RM; La Manna G
Pain Pract; 2017 Jun; 17(5):604-615. PubMed ID: 27589376
[TBL] [Abstract][Full Text] [Related]
33. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
Heiskanen T; Olkkola KT; Kalso E
Clin Pharmacol Ther; 1998 Dec; 64(6):603-11. PubMed ID: 9871425
[TBL] [Abstract][Full Text] [Related]
34. Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.
Kummer O; Hammann F; Moser C; Schaller O; Drewe J; Krähenbühl S
Eur J Clin Pharmacol; 2011 Jan; 67(1):63-71. PubMed ID: 20857093
[TBL] [Abstract][Full Text] [Related]
35. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.
Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K
Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole drastically increases exposure to oral oxycodone.
Hagelberg NM; Nieminen TH; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
Eur J Clin Pharmacol; 2009 Mar; 65(3):263-71. PubMed ID: 18836708
[TBL] [Abstract][Full Text] [Related]
37. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
[TBL] [Abstract][Full Text] [Related]
38. Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone.
Beaver WT; Wallenstein SL; Rogers A; Houde RW
J Pharmacol Exp Ther; 1978 Oct; 207(1):92-100. PubMed ID: 359779
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetics of oral oxycodone in patients after total gastric resection.
Szałek E; Karbownik A; Murawa D; Połom K; Tezyk A; Gracz J; Grabowski T; Grześkowiak E; Biczysko-Murawa A; Murawa P
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3126-33. PubMed ID: 25392115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]